In vitro Activity of Eravacycline and Risk Factors for Carbapenem-Resistant Acinetobacter Baumannii Infections in Patients with Respiratory Diseases: A Retrospective Cohort Study

体外埃拉环素活性及呼吸系统疾病患者碳青霉烯耐药鲍曼不动杆菌感染的危险因素:一项回顾性队列研究

阅读:1

Abstract

BACKGROUND: Carbapenem-resistant Acinetobacter baumannii (CRAB) infections, particularly among respiratory patients, are associated with high mortality rates and substantial healthcare costs, exceeding $1.2 billion annually. Current the medications are recommended therapies, including Colistin and Tigecycline, face significant limitations, such as nephrotoxicity and inadequate lung tissue penetration. In contrast, Eravacycline (ERV), a novel fluorocycline, exhibits potent activity against multidrug-resistant Gram-negative pathogens and may help mitigate these limitations. PATIENTS AND METHODS: A retrospective analysis was conducted on 1071 CRAB isolates obtained from 524 respiratory patients at Shaanxi Provincial People's Hospital in 2024. Bacterial identification was performed using mass spectrometry (Zhongyuan Co). while drug susceptibility testing was carried out using the BD Phoenix M50 (Becton Dickinson) and E-test strips (Liofilchem). Multivariable logistic regression was applied to identify independent risk factors, including age, intubation history, comorbidities, and the use of feeding tubes, with adjusted odds ratios (OR), 95% confidence intervals (CI), and P-values reported. RESULTS: Tracheal intubation emerged as the strongest independent risk factor for CRAB acquisition (OR=3.325, 95% CI: 2.273-4.865, P<0.001). Resistance to β-lactam antibiotics exceeded 96% (Ceftazidime: 96.56%, Ceftriaxone: 97.14%). C-reactive Protein (CRP) (OR=1.001, 95% CI: 0.996-1.006, P=0.004) and interleukin-6 (IL-6) (P<0.001) independently predicted mortality, with SAA demonstrating a strong association with risk (OR = 1.001, 95% CI: 0.999-1.002, P = 0.006). CONCLUSION: Endotracheal intubation significantly contributes to the transmission of CRAB, underscoring the necessity for employing early respiratory ventilation and ERV as a recommended therapies therapeutic strategy in environments with elevated β-lactam resistance. Serum amyloid A (SAA) and interleukin-6 (IL-6) are important prognostic biomarkers that facilitate risk stratification. The implementation of infection control measures that prioritize intubation-associated practices is essential for alleviating the burden of CRAB infections.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。